Maximum tolerated dose of hyperthermic intraperitoneal oxaliplatin 30 Days Post Treatment [clinicaltrials_resource:0383370cb292318d3b32b3eef4294604]
Using the Functional Assessment of Cancer Therapy for Colorectal Cancer (FACT-C) and SF-36 (Quality of Life Evaluation in Dialysis Patients) questionnaires, the quality of life following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPC) will be reported and compared to the preoperative baseline.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Maximum tolerated dose of hyperthermic intraperitoneal oxaliplatin 30 Days Post Treatment [clinicaltrials_resource:0383370cb292318d3b32b3eef4294604]
Using the Functional Assessment of Cancer Therapy for Colorectal Cancer (FACT-C) and SF-36 (Quality of Life Evaluation in Dialysis Patients) questionnaires, the quality of life following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPC) will be reported and compared to the preoperative baseline.
Bio2RDF identifier
0383370cb292318d3b32b3eef4294604
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0383370cb292318d3b32b3eef4294604
measure [clinicaltrials_vocabulary:measure]
Maximum tolerated dose of hyperthermic intraperitoneal oxaliplatin
time frame [clinicaltrials_vocabulary:time-frame]
30 Days Post Treatment
description
Using the Functional Assessmen ...... to the preoperative baseline.
identifier
clinicaltrials_resource:0383370cb292318d3b32b3eef4294604
title
Maximum tolerated dose of hyperthermic intraperitoneal oxaliplatin 30 Days Post Treatment
@en
type
label
Maximum tolerated dose of hype ...... 3370cb292318d3b32b3eef4294604]
@en